Evelo Biosciences, Inc.

NORTHERN TRUST CORP EVLO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

94,330

Value ($000)

17

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	17	0.0%	94,330	3/31/2023
2022 Q4	2/13/2023	153	0.0%	94,970	12/31/2022
2022 Q3	11/14/2022	199	0.0%	95,272	9/30/2022
2022 Q2	8/12/2022	152	0.0%	72,135	6/30/2022
2022 Q1	5/13/2022	973	0.0%	286,971	3/31/2022
2021 Q4	2/8/2022	1,824	0.0%	300,436	12/31/2021
2021 Q3	11/15/2021	2,100	0.0%	298,136	9/30/2021
2021 Q2	8/13/2021	4,433	0.0%	322,651	6/30/2021
2021 Q1	5/12/2021	2,727	0.0%	254,880	3/31/2021
2020 Q4	2/11/2021	2,759	0.0%	228,170	12/31/2020
2020 Q3	11/16/2020	1,177	0.0%	223,368	9/30/2020
2020 Q2	8/14/2020	851	0.0%	173,639	6/30/2020
2020 Q1	5/14/2020	561	0.0%	149,506	3/31/2020
2019 Q4	2/14/2020	567	0.0%	139,641	12/31/2019